Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins

被引:42
作者
Jiang, Wei-Qin [1 ,3 ]
Zhong, Ze-Huai [1 ,3 ]
Nguyen, Akira [1 ,3 ]
Henson, Jeremy D. [1 ,3 ]
Toouli, Christian D. [1 ,3 ]
Braithwaite, Antony W. [2 ,3 ]
Reddel, Roger R. [1 ,3 ]
机构
[1] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW 2145, Australia
[2] Childrens Med Res Inst, Cell Transformat Unit, Westmead, NSW 2145, Australia
[3] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia
基金
英国医学研究理事会;
关键词
PROMYELOCYTIC LEUKEMIA BODIES; HUMAN TUMOR-CELLS; FRAUMENI SYNDROME FIBROBLASTS; MAMMARY EPITHELIAL-CELLS; LACKING FUNCTIONAL P53; WILD-TYPE P53; MAMMALIAN-CELLS; MRE11/RAD50/NBS1; COMPLEX; EPIGENETIC REGULATION; PREMATURE SENESCENCE;
D O I
10.1083/jcb.200810084
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alternative lengthening of telomeres (ALT) is a recombination-mediated process that maintains telomeres in telomerase-negative cancer cells. In asynchronously dividing ALT-positive cell populations, a small fraction of the cells have ALT-associated promyelocytic leukemia nuclear bodies (APBs), which contain (TTAGGG)n DNA and telomere-binding proteins. We found that restoring p53 function in ALT cells caused p21 up-regulation, growth arrest/senescence, and a large increase in cells containing APBs. Knockdown of p21 significantly reduced p53-mediated induction of APBs. Moreover, we found that heterochromatin protein 1 (HP1) is present in APBs, and knockdown of HP1 alpha and/or HP1 gamma prevented p53-mediated APB induction, which suggests that HP1-mediated chromatin compaction is required for APB formation. Therefore, although the presence of APBs in a cell line or tumor is an excellent qualitative marker for ALT, the association of APBs with growth arrest/senescence and with "closed" telomeric chromatin, which is likely to repress recombination, suggests there is no simple correlation between ALT activity level and the number of APBs or APB-positive cells.
引用
收藏
页码:797 / 810
页数:14
相关论文
共 80 条
  • [1] The epigenetic regulation of mammalian telomeres
    Blasco, Maria A.
    [J]. NATURE REVIEWS GENETICS, 2007, 8 (04) : 299 - 309
  • [2] Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: Effect of ectopic hTERT
    Brachner, A
    Sasgary, S
    Pirker, C
    Rodgarkia, C
    Mikula, M
    Mikulits, W
    Bergmeister, H
    Setinek, U
    Wieser, M
    Chin, SF
    Caldas, C
    Micksche, M
    Cerni, C
    Berger, W
    [J]. CANCER RESEARCH, 2006, 66 (07) : 3584 - 3592
  • [3] Bypass of senescence after disruption of p21(CIP1/WAF1) gene in normal diploid human fibroblasts
    Brown, JP
    Wei, WY
    Sedivy, JM
    [J]. SCIENCE, 1997, 277 (5327) : 831 - 834
  • [4] TELOMERE ELONGATION IN IMMORTAL HUMAN-CELLS WITHOUT DETECTABLE TELOMERASE ACTIVITY
    BRYAN, TM
    ENGLEZOU, A
    GUPTA, J
    BACCHETTI, S
    REDDEL, RR
    [J]. EMBO JOURNAL, 1995, 14 (17) : 4240 - 4248
  • [5] Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
    Bryan, TM
    Englezou, A
    DallaPozza, L
    Dunham, MA
    Reddel, RR
    [J]. NATURE MEDICINE, 1997, 3 (11) : 1271 - 1274
  • [6] A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT
    Cerone, MA
    Autexier, C
    Londoño-Vallejo, JA
    Bacchetti, S
    [J]. ONCOGENE, 2005, 24 (53) : 7893 - 7901
  • [7] Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs
    Chang, BD
    Xuan, YZ
    Broude, EV
    Zhu, HM
    Schott, B
    Fang, J
    Roninson, IB
    [J]. ONCOGENE, 1999, 18 (34) : 4808 - 4818
  • [8] CHROMOSOMAL LOCALIZATION OF HUMAN HOMOLOGS OF THE DROSOPHILA HETEROCHROMATIN PROTEIN-1 (HP1) GENE
    CHEVILLARD, C
    REIK, W
    MCDERMOTT, M
    FONTES, M
    MATTEI, MG
    SINGH, PB
    [J]. MAMMALIAN GENOME, 1993, 4 (02) : 124 - 126
  • [9] The Drosophila Mre11/Rad50 complex is required to prevent both telomeric fusion and chromosome breakage
    Ciapponi, L
    Cenci, G
    Ducau, J
    Flores, C
    Johnson-Schlitz, D
    Gorski, MM
    Engels, WR
    Gatti, M
    [J]. CURRENT BIOLOGY, 2004, 14 (15) : 1360 - 1366
  • [10] Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA
    D'Alcontres, Martina Stagno
    Mendez-Bermudez, Aaron
    Foxon, Jennifer L.
    Royle, Nicola J.
    Salomoni, Paolo
    [J]. JOURNAL OF CELL BIOLOGY, 2007, 179 (05) : 855 - 867